Clinical and prognostic features of plasmacytomas: A multicenter study of Turkish Oncology Group-Sarcoma Working Party

American Journal of Hematology

Volumn 83, Issue 9, 2008, Pages 702-707

  Kilciksiz, Sevil ^a   Celik, Omur Karakoyun ^b   Pak, Yucel ^c   Demiral, Ayse Nur ^d   Pehlivan, Mustafa ^a   Orhan, Okan ^e   Tokatli, Fusun ^f   Agaoglu, Fulya ^g   Zincircioglu, Burhanedtin ^h   Atasoy, Beste Melek ⁱ   Ozseker, Naciye ^j   Yersal, Ozlem ^k   Niang, Umar ^l   Haydaroglu, Ayfer ^m  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c GAZI UNIVERSITY   (Turkey)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

^e ERCIYES UNIVERSITY   (Turkey)

^f TRAKYA UNIVERSITY   (Turkey)

^g ISTANBUL UNIVERSITY   (Turkey)

^h DICLE UNIVERSITY   (Turkey)

ⁱ MARMARA UNIVERSITY   (Turkey)

^j Lutfi Kirdar Training and Research Hospital   (Turkey)

^k ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^l Izmir Oncology Center   (Turkey)

^m EGE UNIVERSITY   (Turkey)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CORNEA INJURY; EXCISION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; OVERALL SURVIVAL; PATHOLOGIC FRACTURE; PLASMACYTOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RELAPSE; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR LOCALIZATION; TUMOR VOLUME; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLASMACYTOMA; PROGNOSIS; RADIOTHERAPY DOSAGE; RISK; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TURKEY;

EID: 51449122235     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21211     Document Type: Article

References (40)

1. Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96:2037-2044.
2. Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol 2002;3:255-259.
3. Ozsahin M, Tsang RW, Poortmans P, et al. Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients. Int J Radiat Oncol Biol Phys 2006;64:210-217.
4. Tong D, Griffin TW, Laramore GE, et al. Solitary plasmacytoma of bone and soft tissues. Radiology 1980;135:195-198.
5. Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore) 1976;55:217-238.
6. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988;5:346-364.
7. Hussong JW, Perkins SL, Schnitzer B, et al. Extramedullary plasmacytoma. A form of marginal zone cell lymphoma? Am J Clin Pathol 1999;111:111-116.
8. Aalto Y, Nordling S, Kivioja AH, et al. Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma. Genes Chromosomes Cancer 1999;25:104-107.
9. Mendenhall CM, Thar TL, Million RR. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1980;6:1497-1501.
10. Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 1999;85:2305-2314.
11. Galieni P, Cavo M, Pulsoni A, et al. Clinical outcome of extramedullary plasmacytoma. Haematologica 2000;85:47-51.
12. Dimopoulos MA, Kiamouris C, Moulopoulos LA. Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am 1999;13:1249-57.
13. Tournier-Rangeard L, Lapeyre M, Graff-Caillaud R et al. Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control. Int J Radiat Oncol Biol Phys 2006;64:1013-1017.
14. Michalaki VJ, Hall J, Henk JM, et al. Definitive radiotherapy for extramedullary plasmacytomas of the head and neck. Br J Radiol 2003;76:738-741.
15. Liebross RH, Ha CS, Cox JD, et al. Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol 1999;52:245-249.
16. Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Huntingt) 2000;14:10110-8,111; Discussion 111-112, 115.
17. Tsang RW, Gospodarowicz MK, Pintilie M, et al. Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome. Int J Radiat Oncol Biol Phys 2001;50:113-120.
18. Knowling MA, Harwood AR, Bergsagel DE. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol 1983;1:255-262.
19. Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 1990;17:293-303.
20. Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992;69:1513-1517.
21. Bolek TW, Marcus RB, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys 1996;36:329-333.
22. Susnerwala SS, Shanks JH, Banerjee SS, et al. Extramedullary plasmacytoma of the head and neck region: Clinicopathological correlation in 25 cases. Br J Cancer 1997;75:921-927.
23. Shih LY, Dunn R Leung WM, et al. Localised plasmacytomas in Taiwan: Comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone. Br J Cancer 1995;71:128-133.
24. Soutar R, Lucraft H, Jackson G, et al. Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology: Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Clin Oncol (R Coll Radiol) 2004;16:405-413.
25. Kumar S, Fonseca R, Dispenzieri A, et al. Prognostic value of angiogenesis in solitary bone plasmacytoma. Blood 2003;101:1715-1717.
26. Frassica DA, Frassica FJ, Schray MF, et al. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys 1989;16:43-48.
27. Liebross RH, Ha CS, Cox JD, et al. Solitary bone plasmacytoma: Outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys 1998;41:1063-1067.
28. Weber DM. Solitary Bone and Extramedullary Plasmacytoma. Hematology 2005. pp 373-376.
29. Hall EJ, editor. Radiobiology for the Radiologist. Philadelphia: Lippincott; 2006. pp 378-397.
30. Padhani AR, Ollivier L. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: Implications for diagnostic radiologists. Br J Radiol 2001;74:983-986.
31. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958:53:457-481.
32. Peto R, Pike MC. Conservatism of the approximation (0-E)2/E in the log-rank test for survival data or tumor incidence data. Biometrics 1973;29:579-588.
33. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972:34:187.
34. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13-47.
35. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
36. Knobel D, Zouhair A, Tsang RW, et al. Rare Cancer Network. Prognostic factors in solitary plasmacytoma of the bone: A multicenter Rare Cancer Network study. BMC Cancer 2006;6:118.
37. Bataille R, Sany J. Solitary myeloma: Clinical and prognostic features of a review of 114 cases. Cancer 1981;48:845-851.
38. Jyothirmayi R, Gangadharan VP, Nair MK, Rajan B. Radiotherapy in the treatment of solitary plasmacytoma. Br J Radiol 1997;70:511-516.
39. Chao MW, Gibbs P, Wirth A, et al. Radiotherapy in the management of solitary extramedullary plasmacytoma. Intern Med J 2005;35:211-215.
40. Guidelines Working Group of the UK Myeloma Forum (UKMF). Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 2004;124:717-726.